![]()
|
|
||||||||
(Received for publication, February 28, 1997, and in revised form, May 5, 1997)
From the Department of Pathology and Kaplan Cancer Center, New York
University School of Medicine, New York, New York 10016
Daudi B lymphoblastoid cells are highly sensitive
to the anti-growth and anti-viral effects of interferon (IFN). Unlike
many cell lines, these cells show prolonged transcription of
IFN-stimulated genes following treatment with IFN-
Volume 272, Number 35,
Issue of August 29, 1997
pp. 21872-21877
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Responsiveness by the Duration
of Janus Kinase Activity
. This prolonged
response correlated with the continued presence of the activated
transcription factor, IFN-stimulated gene factor 3 (ISGF3). Pulse-chase
labeling experiments indicated that the half-life of the
phosphorylation of signal transducers and activators of transcription
(Stat)1 and Stat2 was short (<2 h) although the turnover of the
proteins themselves was slow (>24 h), indicative of a constitutive
phosphatase activity. The administration of protein-tyrosine kinase
inhibitors at any time point during IFN stimulation led to rapid
inhibition of the response, indicating that tyrosine kinase activity
was continuously required. Catalytic activity of Jak1 and Tyk2 kinases remained elevated for prolonged periods following stimulation. Continuous presence of IFN-
was necessary for maintaining prolonged activation of ISGF3 and of Janus kinases, an activity that was blocked
by antibodies to IFN-
or by cycloheximide. Conditioned medium of
IFN-
-stimulated cells was capable of stimulating STAT activation in
naive cells. Taken together, these results suggest that the response to
IFN-
is controlled by the duration of stimulated Janus kinase
activity over the background of constitutive dephosphorylation and that
this response can be sustained by autocrine secretion of IFN-
.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Marchetti, M.-N. Monier, A. Fradagrada, K. Mitchell, F. Baychelier, P. Eid, L. Johannes, and C. Lamaze Stat-mediated Signaling Induced by Type I and Type II Interferons (IFNs) Is Differentially Controlled through Lipid Microdomain Association and Clathrin-dependent Endocytosis of IFN Receptors Mol. Biol. Cell, July 1, 2006; 17(7): 2896 - 2909. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Severa, M. E. Remoli, E. Giacomini, J. Ragimbeau, R. Lande, G. Uze, S. Pellegrini, and E. M. Coccia Differential responsiveness to IFN-{alpha} and IFN-{beta} of human mature DC through modulation of IFNAR expression J. Leukoc. Biol., June 1, 2006; 79(6): 1286 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ulane, A. Kentsis, C. D. Cruz, J.-P. Parisien, K. L. Schneider, and C. M. Horvath Composition and Assembly of STAT-Targeting Ubiquitin Ligase Complexes: Paramyxovirus V Protein Carboxyl Terminus Is an Oligomerization Domain J. Virol., August 15, 2005; 79(16): 10180 - 10189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Grace, S. Lee, S. Bradshaw, J. Chapman, J. Spond, S. Cox, M. DeLorenzo, D. Brassard, D. Wylie, S. Cannon-Carlson, et al. Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-{alpha} Antiviral and Antiproliferative Activities through the JAK/STAT Signaling Pathway J. Biol. Chem., February 25, 2005; 280(8): 6327 - 6336. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer, A. Marg, P. Lemke, B. Wiesner, and U. Vinkemeier DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1 Genes & Dev., August 15, 2003; 17(16): 1992 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Schlosser, M. Schuler, C. P. Berg, K. Lauber, K. Schulze-Osthoff, F. W. Schmahl, and S. Wesselborg Ribavirin and Alpha Interferon Enhance Death Receptor-Mediated Apoptosis and Caspase Activation in Human Hepatoma Cells Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1912 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ulane, J. J. Rodriguez, J.-P. Parisien, and C. M. Horvath STAT3 Ubiquitylation and Degradation by Mumps Virus Suppress Cytokine and Oncogene Signaling J. Virol., June 1, 2003; 77(11): 6385 - 6393. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dondi, L. Rogge, G. Lutfalla, G. Uze, and S. Pellegrini Down-Modulation of Responses to Type I IFN Upon T Cell Activation J. Immunol., January 15, 2003; 170(2): 749 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. ten Hoeve, M. de Jesus Ibarra-Sanchez, Y. Fu, W. Zhu, M. Tremblay, M. David, and K. Shuai Identification of a Nuclear Stat1 Protein Tyrosine Phosphatase Mol. Cell. Biol., August 15, 2002; 22(16): 5662 - 5668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Andrejeva, D. F. Young, S. Goodbourn, and R. E. Randall Degradation of STAT1 and STAT2 by the V Proteins of Simian Virus 5 and Human Parainfluenza Virus Type 2, Respectively: Consequences for Virus Replication in the Presence of Alpha/Beta and Gamma Interferons J. Virol., March 1, 2002; 76(5): 2159 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horsch, M. D. Schaller, and N. E. Hynes The Protein Tyrosine Phosphatase-PEST Is Implicated in the Negative Regulation of Epidermal Growth Factor on PRL Signaling in Mammary Epithelial Cells Mol. Endocrinol., December 1, 2001; 15(12): 2182 - 2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Najarro, P. Traktman, and J. A. Lewis Vaccinia Virus Blocks Gamma Interferon Signal Transduction: Viral VH1 Phosphatase Reverses Stat1 Activation J. Virol., April 1, 2001; 75(7): 3185 - 3196. [Abstract] [Full Text] |
||||
![]() |
D. D. Eason and G. Blanck High Level Class II trans-Activator Induction Does Not Occur with Transient Activation of the IFN-{{gamma}} Signaling Pathway J. Immunol., January 15, 2001; 166(2): 1041 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Begitt, T. Meyer, M. van Rossum, and U. Vinkemeier Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain PNAS, September 5, 2000; (2000) 190318397. [Abstract] [Full Text] |
||||
![]() |
T. Komatsu, K. Takeuchi, J. Yokoo, Y. Tanaka, and B. Gotoh Sendai Virus Blocks Alpha Interferon Signaling to Signal Transducers and Activators of Transcription J. Virol., March 1, 2000; 74(5): 2477 - 2480. [Abstract] [Full Text] |
||||
![]() |
C.-K. Lee, E. Smith, R. Gimeno, R. Gertner, and D. E. Levy STAT1 Affects Lymphocyte Survival and Proliferation Partially Independent of Its Role Downstream of IFN-{gamma} J. Immunol., February 1, 2000; 164(3): 1286 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Yu, Y.-J. Jin, and S. J. Burakoff Cytosolic Tyrosine Dephosphorylation of STAT5. POTENTIAL ROLE OF SHP-2 IN STAT5 REGULATION J. Biol. Chem., January 7, 2000; 275(1): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wen, H. H. Lin, H.-M. Shih, H.-J. Kung, and D. K. Ann Kinase Activation of the Non-receptor Tyrosine Kinase Etk/BMX Alone Is Sufficient to Transactivate STAT-mediated Gene Expression in Salivary and Lung Epithelial Cells J. Biol. Chem., December 31, 1999; 274(53): 38204 - 38210. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Didcock, D. F. Young, S. Goodbourn, and R. E. Randall The V Protein of Simian Virus 5 Inhibits Interferon Signalling by Targeting STAT1 for Proteasome-Mediated Degradation J. Virol., December 1, 1999; 73(12): 9928 - 9933. [Abstract] [Full Text] |
||||
![]() |
D. L. Russell and J. S. Richards Differentiation-Dependent Prolactin Responsiveness and Stat (Signal Transducers and Activators of Transcription) Signaling in Rat Ovarian Cells Mol. Endocrinol., December 1, 1999; 13(12): 2049 - 2064. [Abstract] [Full Text] |
||||
![]() |
C.-K. Lee, R. Gimeno, and D. E. Levy Differential Regulation of Constitutive Major Histocompatibility Complex Class I Expression in T and B Lymphocytes J. Exp. Med., November 15, 1999; 190(10): 1451 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Colantonio, A. Iellem, B. Clissi, R. Pardi, L. Rogge, F. Sinigaglia, and D. D'Ambrosio Upregulation of Integrin alpha 6/beta 1 and Chemokine Receptor CCR1 by Interleukin-12 Promotes the Migration of Human Type 1 Helper T Cells Blood, November 1, 1999; 94(9): 2981 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Haspel and J. E. Darnell Jr. A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1 PNAS, August 31, 1999; 96(18): 10188 - 10193. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Strehlow and C. Schindler Amino-terminal Signal Transducer and Activator of Transcription (STAT) Domains Regulate Nuclear Translocation and STAT Deactivation J. Biol. Chem., October 23, 1998; 273(43): 28049 - 28056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Piehler, L. C. Roisman, and G. Schreiber New Structural and Functional Aspects of the Type I Interferon-Receptor Interaction Revealed by Comprehensive Mutational Analysis of the Binding Interface J. Biol. Chem., December 15, 2000; 275(51): 40425 - 40433. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gamero and A. C. Larner Vanadate Facilitates Interferon alpha -mediated Apoptosis That Is Dependent on the Jak/Stat Pathway J. Biol. Chem., April 20, 2001; 276(17): 13547 - 13553. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Begitt, T. Meyer, M. van Rossum, and U. Vinkemeier Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain PNAS, September 12, 2000; 97(19): 10418 - 10423. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |